Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Opsoclonus-myoclonus syndrome associated with non-metastatic neuroblastoma. Long-term survival. Study of the French Society of Pediatric Oncologists].
Plantaz D, Michon J, Valteau-Couanet D, Coze C, Chastagner P, Bergeron C, Nelken B, Martelli H, Peyroulet MC, Carpentier AF, Armari-Alla C, Pagnier A, Rubie H. Plantaz D, et al. Among authors: nelken b. Arch Pediatr. 2000 Jun;7(6):621-8. doi: 10.1016/s0929-693x(00)80129-3. Arch Pediatr. 2000. PMID: 10911528 French.
Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
Michel G, Leverger G, Leblanc T, Nelken B, Baruchel A, Landman-Parker J, Thuret I, Bergeron C, Bordigoni P, Esperou-Bourdeau H, Perel Y, Vannier JP, Schaison G. Michel G, et al. Among authors: nelken b. Bone Marrow Transplant. 1996 Feb;17(2):191-6. Bone Marrow Transplant. 1996. PMID: 8640165 Clinical Trial.
Induction chemotherapy followed by allogeneic bone marrow transplantation or aggressive consolidation chemotherapy in childhood acute myeloblastic leukemia. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
Michel G, Baruchel A, Tabone MD, Nelken B, Leblanc T, Thuret I, Bordigoni P, Bergeron C, Esperou-Bourdeau H, Perel Y, Vannier JP, De Lumley L, Dommergues JP, Lamagnère JP, Couillaud G, Auvrignon A, Schaison G, Leverger G. Michel G, et al. Among authors: nelken b. Hematol Cell Ther. 1996 Apr;38(2):169-76. doi: 10.1007/s00282-996-0169-7. Hematol Cell Ther. 1996. PMID: 8931998 Clinical Trial.
[Cutaneous symptoms revealing a monoblastic leukemia].
Dalle JH, Mortier L, Roumier C, Laï JL, Catteau B, Delaporte E, Nelken B. Dalle JH, et al. Among authors: nelken b. Arch Pediatr. 2002 Oct;9(10):1046-9. doi: 10.1016/s0929-693x(02)00052-0. Arch Pediatr. 2002. PMID: 12462835 French.
A 22-year French experience with solid tumors in children with Down syndrome.
Satgé D, Sasco AJ, Chompret A, Orbach D, Méchinaud F, Lacour B, Roullet B, Martelli H, Bergeron C, Bertrand Y, Lacombe D, Perel Y, Monteil P, Nelken B, Bertozzi AI, Munzer M, Kanold J, Bernard F, Vekemans MJ, Sommelet D. Satgé D, et al. Among authors: nelken b. Pediatr Hematol Oncol. 2003 Oct-Nov;20(7):517-29. doi: 10.1080/08880010390232727. Pediatr Hematol Oncol. 2003. PMID: 12959856
134 results